Annual D&A
$1.88 M
+$204.00 K+12.17%
31 December 2023
Summary:
C4 Therapeutics annual depreciation & amortization is currently $1.88 million, with the most recent change of +$204.00 thousand (+12.17%) on 31 December 2023. During the last 3 years, it has risen by +$263.00 thousand (+16.26%). CCCC annual D&A is now at all-time high.CCCC Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$442.00 K
-$6000.00-1.34%
30 September 2024
Summary:
C4 Therapeutics quarterly depreciation & amortization is currently $442.00 thousand, with the most recent change of -$6000.00 (-1.34%) on 30 September 2024. Over the past year, it has dropped by -$5000.00 (-1.12%). CCCC quarterly D&A is now -18.90% below its all-time high of $545.00 thousand, reached on 31 March 2023.CCCC Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.77 M
-$5000.00-0.28%
30 September 2024
Summary:
C4 Therapeutics TTM depreciation & amortization is currently $1.77 million, with the most recent change of -$5000.00 (-0.28%) on 30 September 2024. Over the past year, it has dropped by -$203.00 thousand (-10.30%). CCCC TTM D&A is now -10.30% below its all-time high of $1.97 million, reached on 30 September 2023.CCCC TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.2% | -1.1% | -10.3% |
| 3 y3 years | +16.3% | +33.9% | +15.3% |
| 5 y5 years | +47.7% | - | - |
CCCC Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +26.0% | -18.9% | +44.9% | -10.3% | +31.4% |
| 5 y | 5 years | at high | +47.7% | -18.9% | +44.9% | -10.3% | +325.0% |
| alltime | all time | at high | +47.7% | -18.9% | +44.9% | -10.3% | +325.0% |
C4 Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $442.00 K(-1.3%) | $1.77 M(-0.3%) |
| June 2024 | - | $448.00 K(0.0%) | $1.77 M(-0.6%) |
| Mar 2024 | - | $448.00 K(+4.2%) | $1.78 M(-5.2%) |
| Dec 2023 | $1.88 M(+12.2%) | $430.00 K(-3.8%) | $1.88 M(-4.6%) |
| Sept 2023 | - | $447.00 K(-2.4%) | $1.97 M(+1.7%) |
| June 2023 | - | $458.00 K(-16.0%) | $1.94 M(+1.2%) |
| Mar 2023 | - | $545.00 K(+4.6%) | $1.92 M(+14.3%) |
| Dec 2022 | $1.68 M | $521.00 K(+25.5%) | $1.68 M(+13.4%) |
| Sept 2022 | - | $415.00 K(-4.6%) | $1.48 M(+6.1%) |
| June 2022 | - | $435.00 K(+42.6%) | $1.39 M(+3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $305.00 K(-5.6%) | $1.35 M(-9.8%) |
| Dec 2021 | $1.49 M(-7.7%) | $323.00 K(-2.1%) | $1.49 M(-2.7%) |
| Sept 2021 | - | $330.00 K(-14.9%) | $1.53 M(-5.5%) |
| June 2021 | - | $388.00 K(-14.0%) | $1.62 M(-1.7%) |
| Mar 2021 | - | $451.00 K(+23.6%) | $1.65 M(+2.2%) |
| Dec 2020 | $1.62 M(+1.4%) | $365.00 K(-13.1%) | $1.62 M(+29.2%) |
| Sept 2020 | - | $420.00 K(+1.0%) | $1.25 M(+50.5%) |
| June 2020 | - | $416.00 K(0.0%) | $832.00 K(+100.0%) |
| Mar 2020 | - | $416.00 K | $416.00 K |
| Dec 2019 | $1.59 M(+25.3%) | - | - |
| Dec 2018 | $1.27 M | - | - |
FAQ
- What is C4 Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for C4 Therapeutics?
- What is C4 Therapeutics annual D&A year-on-year change?
- What is C4 Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for C4 Therapeutics?
- What is C4 Therapeutics quarterly D&A year-on-year change?
- What is C4 Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for C4 Therapeutics?
- What is C4 Therapeutics TTM D&A year-on-year change?
What is C4 Therapeutics annual depreciation & amortization?
The current annual D&A of CCCC is $1.88 M
What is the all time high annual D&A for C4 Therapeutics?
C4 Therapeutics all-time high annual depreciation & amortization is $1.88 M
What is C4 Therapeutics annual D&A year-on-year change?
Over the past year, CCCC annual depreciation & amortization has changed by +$204.00 K (+12.17%)
What is C4 Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of CCCC is $442.00 K
What is the all time high quarterly D&A for C4 Therapeutics?
C4 Therapeutics all-time high quarterly depreciation & amortization is $545.00 K
What is C4 Therapeutics quarterly D&A year-on-year change?
Over the past year, CCCC quarterly depreciation & amortization has changed by -$5000.00 (-1.12%)
What is C4 Therapeutics TTM depreciation & amortization?
The current TTM D&A of CCCC is $1.77 M
What is the all time high TTM D&A for C4 Therapeutics?
C4 Therapeutics all-time high TTM depreciation & amortization is $1.97 M
What is C4 Therapeutics TTM D&A year-on-year change?
Over the past year, CCCC TTM depreciation & amortization has changed by -$203.00 K (-10.30%)